CANDISE LOVE: Open Payments
NPI 1801102371 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,178 in 169 payments from 39 companies in 2025. Trend: 2023 $2,230 · 2024 $3,966 · 2025 $4,178
Food & beverage: $3,855Education: $240Long term medical supply or device loan: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $475 |
| Novartis Pharmaceuticals Corporation | 15 | $381 |
| ABBVIE INC. | 9 | $318 |
| Daiichi Sankyo Inc. | 13 | $296 |
| Merck Sharp & Dohme LLC | 9 | $241 |
| AstraZeneca Pharmaceuticals LP | 10 | $225 |
| Exelixis Inc. | 6 | $178 |
| Eisai Inc. | 8 | $173 |
| Genentech USA, Inc. | 10 | $155 |
| Lilly USA, LLC | 6 | $138 |
Products named: ENHERTU, KEYTRUDA, KISQALI, RYBREVANT, Lenvima, VERZENIO, RYTELO, ELAHERE.
Industry payments across MI — which companies pay providers there.
